n-demethyltramadol has been researched along with Cancer Pain in 2 studies
*Cancer Pain: Pain that may be caused by or related to cellular, tissue, and systemic changes that occur during NEOPLASM growth, tissue invasion, and METASTASIS. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Itoh, K; Kawakami, J; Naito, T; Suzuki, K; Tanaka, H; Yamada, Y | 1 |
| Hiraide, T; Kawakami, J; Naito, T; Sato, H; Tanaka, H; Yamada, Y | 1 |
2 other study(ies) available for n-demethyltramadol and Cancer Pain
| Article | Year |
|---|---|
A Reversed-Phase Mode LC-MS/MS Method Using a Polysaccharide Chiral Selector for Simultaneous Quantitation of Each Enantiomer of Tramadol and its Metabolites in Human Plasma and Evaluation of CYP-Mediated Stereoselective Demethylation.
Topics: Analgesics, Opioid; Cancer Pain; Chromatography, Liquid; Cytochrome P-450 Enzyme System; Humans; Polysaccharides; Reproducibility of Results; Stereoisomerism; Tandem Mass Spectrometry; Tramadol | 2020 |
Impact of CYP genotype and inflammatory markers on the plasma concentrations of tramadol and its demethylated metabolites and drug tolerability in cancer patients.
Topics: Administration, Oral; Aged; Analgesics, Opioid; Asian People; C-Reactive Protein; Cancer Pain; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System; Female; Genotype; Humans; Interleukin-6; Male; Middle Aged; Neoplasms; Time Factors; Tramadol | 2018 |